These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 421089

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. A comparison of des-amino arginine vasopressin with pitressin tannate as diagnostic agents.
    Hocken AG.
    N Z Med J; 1979 May 23; 89(636):381-2. PubMed ID: 289006
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. A standardized desmopressin test of renal concentrating ability.
    Nadvorníková H, Schück O, Cort JH.
    Clin Nephrol; 1980 Sep 23; 14(3):142-7. PubMed ID: 7418281
    [Abstract] [Full Text] [Related]

  • 25. Differential diagnosis of diabetes insipidus: use of DDAVP to terminate the seven-hour water deprivation test.
    Hendricks SA, Lippe B, Kaplan SA, Lee WN.
    J Pediatr; 1981 Feb 23; 98(2):244-6. PubMed ID: 7463222
    [No Abstract] [Full Text] [Related]

  • 26. The antidiuretic action of 1-deamino-8-D-arginine vasopressin (DDAVP) in man.
    Radó JP, Marosi J, Szende L, Borbély L, Takó J, Fischer J.
    Int J Clin Pharmacol Biopharm; 1976 Apr 23; 13(3):199-209. PubMed ID: 950263
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Increased renal concentrating ability after long-term oral desmopressin lyophilisate treatment contributes to continued success for monosymptomatic nocturnal enuresis.
    Ikeda H, Watanabe T, Isoyama K.
    Int J Urol; 2017 Sep 23; 24(9):698-702. PubMed ID: 28636262
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The effect of DDAVP on intravenous urography.
    Dixon AK, Webb JA, Cattell WR, Fry IK.
    Br J Radiol; 1981 Jun 23; 54(642):484-7. PubMed ID: 7237025
    [Abstract] [Full Text] [Related]

  • 33. [DDAVP loading test (a test on kidney concentrating ability)].
    Shimizu K.
    Nihon Rinsho; 1979 Jun 29; Suppl():2519-20. PubMed ID: 491203
    [No Abstract] [Full Text] [Related]

  • 34. D.D.A.V.P. test in assessment of renal function during lithium therapy.
    Asplund K, Wahlin A, Rapp W.
    Lancet; 1979 Mar 03; 1(8114):491. PubMed ID: 85073
    [No Abstract] [Full Text] [Related]

  • 35. Urine osmolality, cyclic AMP and aquaporin-2 in urine of patients under lithium treatment in response to water loading followed by vasopressin administration.
    Wilting I, Baumgarten R, Movig KL, van Laarhoven J, Apperloo AJ, Nolen WA, Heerdink ER, Knoers NV, Egberts AC.
    Eur J Pharmacol; 2007 Jul 02; 566(1-3):50-7. PubMed ID: 17466972
    [Abstract] [Full Text] [Related]

  • 36. Effect of antidiuretic hormone and dibutyryl cAMP upon the urinary concentrating capacity in neonatal piglets.
    Joppich R, Schrader J, Häberle DA.
    Pediatr Res; 1980 Nov 02; 14(11):1234-7. PubMed ID: 6256711
    [Abstract] [Full Text] [Related]

  • 37. Lithium-induced reduction in urinary concentrating ability and urinary aquaporin 2 (AQP2) excretion in healthy volunteers.
    Walker RJ, Weggery S, Bedford JJ, McDonald FJ, Ellis G, Leader JP.
    Kidney Int; 2005 Jan 02; 67(1):291-4. PubMed ID: 15610254
    [Abstract] [Full Text] [Related]

  • 38. Detection of renal impairment in cases of chronic abuse of analgesics by administration of desamino-D-arginine vasopressin.
    Wambach G, Bönner G, Kleinpass H, Dopatka A, Kaufmann W.
    Arzneimittelforschung; 1989 Mar 02; 39(3):387-90. PubMed ID: 2569306
    [Abstract] [Full Text] [Related]

  • 39. [A warning about the kidney concentrating test in children using DDAVP as suggested by Janda and his associates].
    Neméthová V, Lehotská V, Lichardus B.
    Cesk Pediatr; 1983 Nov 02; 38(11):686-7. PubMed ID: 6652789
    [No Abstract] [Full Text] [Related]

  • 40. DDAVP-induced maternal hyposmolality increases ovine fetal urine flow.
    Nijland MJ, Ross MG, Kullama LK, Bradley K, Ervin MG.
    Am J Physiol; 1995 Feb 02; 268(2 Pt 2):R358-65. PubMed ID: 7864229
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.